A new research found low levels of the protein amyloid beta in the spinal fluid as common in both, the people with HIV-related cognitive deficits and Alzheimer's-related dementia.
The findings may be able to help doctors distinguish patients with HIV-related memory loss and those with early Alzheimer's.
Partial Amyloid Beta Inhibition Improves Memory in Alzheimer's
An animal study conducted by New York University researchers suggests that partially inhibiting an enzyme that initiates the release of amyloid beta may help improve memory dysfunction.
An animal study conducted by New York University researchers suggests that partially inhibiting an enzyme that initiates the release of amyloid beta may help improve memory dysfunction.
Study's lead author David Clifford of Washington and colleagues tpo ook at the spinal fluid of 49 HIV patients with cognitive impairments, 21 HIV patients with normal cognitive function, 68 patients with mild Alzheimer's and 50 normal, healthy "controls."
The Alzheimer's patients were older (average age 74) than the controls (average age 50), impaired HIV patients (average age 48) and cognitively normal HIV patients (average age 43).
Small Clusters Of Amyloid Beta, Not Plaques, Could Be Behind Brain Damage In Alzheimer?s Disease
Small clusters of amyloid beta, not plaques, could be behind brain damage in Alzheimer’s disease.
Small clusters of amyloid beta, not plaques, could be behind brain damage in Alzheimer’s disease.
They also looked at other biomarkers associated with Alzheimer's, including tau, a protein found in tangled nerve fibers in Alzheimer's patients.
Advertisement
New Approach to Alzheimer?s Treatments
Researchers at New York University School of Medicine have come up with a novel way to prevent the accumulation of protein plaques that are the hallmark of Alzheimer’s disease.
Researchers at New York University School of Medicine have come up with a novel way to prevent the accumulation of protein plaques that are the hallmark of Alzheimer’s disease.
But they were surprised to find the same low levels in the spinal fluid of HIV patients with cognitive dysfunction. Both groups of patients had significantly lower amyloid beta levels than HIV patients without cognitive impairments and the normal controls.
Advertisement
Soon, A Simple Way To Determine Symptoms Of Alzheimer?s Disease In Women
A new study concludes that a simple blood test could soon determine if a woman is suffering from Alzheimer's disease, long before any signs of illness.
A new study concludes that a simple blood test could soon determine if a woman is suffering from Alzheimer's disease, long before any signs of illness.
The study appears in the journal Neurology.
Source-ANI
TRI
